Cannabis Bioscience International Holdings, Inc. (CBIH) Revenue (2022 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted Revenue of $11205.0 for Q1 2026, down 78.96% sequentially from $53266.0 in Q4 2025, and down 24.95% YoY from $14931.0 in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) Revenue (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported Revenue for 5 years, with the latest figure at $11205.0 in Q1 2026.
- Quarterly Revenue fell 24.95% year-over-year to $11205.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $123627.0 (down 64.05% YoY) and the FY2025 annual result came in at $303022.0, up 21.77% from the prior year.
- Revenue retreated to $11205.0 in Q1 2026 per CBIH's latest filing, from $53266.0 in the prior quarter.
- Over five years, Revenue peaked at $178887.0 in Q3 2024 and troughed at $11205.0 in Q1 2026.
- A 5-year average of $58627.1 and a median of $52259.0 in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue jumped 145.65% in 2024, then plunged 86.47% in 2025.
- Over 5 years, Revenue stood at $82581.0 in 2022, then declined by 22.81% to $63748.0 in 2023, then rose by 16.47% to $74248.0 in 2024, then declined by 28.26% to $53266.0 in 2025, then slumped by 78.96% to $11205.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $11205.0, $53266.0, and $24200.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 11,205.00 |
| Nov 30, 2025 | 53,266.00 |
| Aug 31, 2025 | 24,200.00 |
| May 31, 2025 | 34,956.00 |
| Feb 28, 2025 | 14,931.00 |
| Nov 30, 2024 | 74,248.00 |
| Aug 31, 2024 | 178,887.00 |
| May 31, 2024 | 75,862.00 |
| Feb 29, 2024 | 36,411.00 |
| Nov 30, 2023 | 63,748.00 |
| Aug 31, 2023 | 72,821.00 |
| May 31, 2023 | 46,412.00 |
| Feb 28, 2023 | 51,252.00 |
| Nov 30, 2022 | 82,581.00 |